Tuesday, 12 January 2021

TIK-TOC Study needs Community Champions

What is the TIK-TOC Study?

  • It’s a feasibility study to test whether a multi-faceted vague cancer symptom awareness campaign to support entry into the Rapid Diagnostic Clinic can be delivered, whether the public thought the campaign was acceptable, and whether the campaign reached people in the local community.  We also need to find out whether we can collect the data needed for a future trial to test if the campaign works.
  • It’s a 6 month intervention to raise vague cancer symptom awareness, modify barriers to help seeking, reduce cancer fear and fatalism, and prompt help seeking through social support. This is where the community champions come in – we want them to help with raising cancer symptom awareness in their local community.
  • Campaign will be run in Cwm Taf Morgannwg with Swansea as a comparator area.  It will target adults (18+) to mirror the RDC referral criteria.
  • The study will look at how many patients agree to complete a questionnaire to measure how long they took from spotting a symptom to visiting the GP; whether we can access hospital data such as the number of patients referred for suspected cancer, and whether we can estimate the costs of the awareness campaign.

 Key duties of the ‘Community Champions’ role are to:

  • Distribute campaign materials to people in the local community.
  • Host events in the community and online.
  • Work collaboratively with the study team and attend meetings.

 

We are looking for 5 people who are:

  • Based in the CTM UHB area.
  • Connected a range of social groups, organisations and clubs in the area.
  • Enthusiastic, friendly and approachable.
  • Feel able to approach people to talk about cancer.
  • Have access to a computer and are computer literate.
  • Self-motivated.

 It’s a voluntary role but with honorarium. Travel expenses are paid. Training, PPE, and a mobile phone will be provided.

The role is for eight hours a week for eight months (starting from May 2021).

Manylion Pellach        Further information

No comments:

Post a Comment